BL-C Kit
KIT · betamethasone sodium phosphate, betamethasone acetate, lidocaine, iodixanol, povidine iodine
United StatesActive
Marketing holder: Asclemed USA, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- betamethasone sodium phosphate, betamethasone acetate, lidocaine, iodixanol, povidine iodine
Registration
- Registration number
- 76420-892
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INFILTRATION, INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR, INTRAVASCULAR, PERINEURAL, TOPICAL
Sources
- product · openFDA NDC · 76420-892 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 76420-892 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 76420-892 · Verified 2026-10-09 · open in source